Skip to content

Management of Acute Conjunctivitis

Efficacy of Triphala Parisheka in the Management of Amaja Netra Roga (Acute Conjunctivitis) â??A Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/011018
Enrollment
30
Registered
2017-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Complaining of redness of eyes, pain in eyes, burning sensation, watery discharge, foreign body sensation

Interventions

Intervention1: Group A: Triphala Parisheka 3 times a day for 7 days Control Intervention1: Group B: Moxifloxacin 0.5% (eye drops) one drop 3 times a day in each eye for 7 days

Sponsors

Institute For Post Graduate Teaching And Research In Ayurveda Gujarat Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients will be selected on the basis of signs and symptoms of Amavastha of Netra Roga (Acute Conjunctivitis). 2 Age between 18-50 years

Exclusion criteria

Exclusion criteria: 1 Patients not willing for attending the hospital for the procedures daily and registration. 2 Age less than 18 and more than 50 years. 3 Complicated Conjunctivitis with Glaucoma, Uveitis, Corneal Ulcer, Panophthalmitis, Dacryocystitis, Episcleritis and Ocular trauma. 4 Patients presenting after 7 days of ocular complaints. 5 Special type of conjunctivitis, eg: Kerato conjunctivitis, Allergic conjunctivitis, Viral conjunctivitis, Trachoma. 6 Patients suffering from other specific systemic disease

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will exert a significant action over Acute Conujunctivitis(Amaja Netra Roga)Timepoint: 1 week

Secondary

MeasureTime frame
Significant relief in the sign and symptoms of Acute Conjunctivitis (Amaja Netra Roga)Timepoint: 1 week

Countries

India

Contacts

Public ContactDr D B Vaghela

IPGT AND RA Jamnagar

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026